Obtenga las últimas noticias sobre las acciones de Fortrea Holdings con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de FTRE

Últimas noticias sobre

FORTREA HOLDINGS INC

Fortrea Holdings

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

News

Pre-Market Outlook

Markets

Trading Ideas

BEKE

FTRE

MNDY

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: MNDY, SLF, BRT, FTRE y BEKE.

5 acciones en el foco este lunes: MNDY, SLF, BRT, FTRE y BEKE

Fortrea Holdings Inc

Legal

Press Releases

FTRE DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Class Action – FTRE

FORTREA FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Fortrea Holdings (FTRE) of The August 1st Deadline and Urges Investors to Contact The Firm

Investors who lost money on Fortrea Holdings Inc.(FTRE) should contact Levi & Korsinsky about pending Class Action - FTRE

DEADLINE ALERT for FTRE, BHVN, and NEOG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea Holdings

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Management

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

Earnings

Fortrea Reports Second Quarter 2025 Results

Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit

Kuehn Law Encourages Investors of Fortrea Holdings, Inc. to Contact Law Firm

BHVN

NEOG

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Cytek Biosciences

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Fortrea Holdings Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL